Home › Parkinson's Disease
Parkinson's Disease clinical trials recruiting in the U.S.
211 studies for Parkinson's Disease are recruiting participants at sites across the United States.
Parkinson's disease (PD) is a movement disorder. It causes tremors, stiffness, and slow movement. It gets worse over time. Learn what can help.
Cities with the most studies
- New York City, NY25 studies
- Cleveland, OH19 studies
- Boston, MA19 studies
- Minneapolis, MN17 studies
- New Haven, CT15 studies
- San Francisco, CA14 studies
- Nashville, TN14 studies
- Miami, FL14 studies
- Philadelphia, PA14 studies
- Farmington Hills, MI13 studies
- Tampa, FL13 studies
- Charleston, SC13 studies
- Chicago, IL13 studies
- Birmingham, AL12 studies
- Atlanta, GA12 studies
- Gainesville, FL12 studies
- Ann Arbor, MI11 studies
- Portland, OR11 studies
- Boca Raton, FL11 studies
- Orlando, FL10 studies
- Washington, DC10 studies
- Los Angeles, CA10 studies
- Aurora, CO10 studies
- Dallas, TX9 studies
- Round Rock, TX9 studies
- Mountain View, CA9 studies
- Houston, TX9 studies
- Baltimore, MD9 studies
- Durham, NC9 studies
- St. Louis, MO9 studies
- Kirkland, WA8 studies
- Kansas City, KS8 studies
- Spokane, WA8 studies
- San Diego, CA7 studies
- Phoenix, AZ6 studies
- Las Vegas, NV6 studies
- Pittsburgh, PA6 studies
- Columbus, OH6 studies
- Lexington, KY6 studies
- Hollywood, FL5 studies
By state
- Alabama13 studies
- Arizona13 studies
- Arkansas5 studies
- California37 studies
- Colorado15 studies
- Connecticut20 studies
- Delaware3 studies
- District of Columbia4 studies
- Florida38 studies
- Georgia13 studies
- Illinois17 studies
- Indiana4 studies
- Iowa4 studies
- Kansas10 studies
- Kentucky9 studies
- Louisiana3 studies
- Maryland15 studies
- Massachusetts20 studies
- Michigan22 studies
- Minnesota20 studies
- Missouri10 studies
- Nevada6 studies
- New Jersey3 studies
- New Mexico5 studies
- New York32 studies
- North Carolina15 studies
- Ohio25 studies
- Oklahoma4 studies
- Oregon11 studies
- Pennsylvania18 studies
- South Carolina13 studies
- Tennessee17 studies
- Texas25 studies
- Utah5 studies
- Vermont4 studies
- Virginia10 studies
- Washington15 studies
- Wisconsin3 studies
Recently updated studies
Phase 2 Trial of Tributyrin in People With Parkinson's Disease and Cognitive Impairments
RecruitingPhase 1/2
Ages 45 and older · All sexes · Updated Nov 13, 2026 · NCT07154511Neocortical Microarchitecture of Executive Function
Recruiting
Ages 45 to 85 · All sexes · Updated Nov 13, 2026 · NCT06778135A Trial Investigating Lu AF28996 in Adults With Parkinson's Disease Who Have Motor Fluctuations
RecruitingPhase 2
Ages 40 to 85 · All sexes · Updated Nov 13, 2026 · NCT07514858Adaptango Performance PRocess for Older Adults Community reHabilitation
RecruitingHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Nov 13, 2026 · NCT07824128Stimulating Specific Brain Areas (VOP/VIM) With Electricity to Improve Movement and Muscle Control
Recruiting
Ages 18 to 75 · All sexes · Updated Nov 12, 2026 · NCT07056361SAD Study in Patients With Parkinson's Disease and Motor Fluctuations
RecruitingPhase 1
Ages 40 to 80 · All sexes · Updated Nov 12, 2026 · NCT07422675Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry
RecruitingObservational study
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT02071134Deep Brain Stimulation Therapy in Movement Disorders
Recruiting
Ages 18 to 100 · All sexes · Updated Nov 12, 2026 · NCT02119611Deep Brain Stimulation Surgery for Movement Disorders
Recruiting
Ages 18 to 99 · All sexes · Updated Nov 12, 2026 · NCT01581580Deep Brain Stimulation (DBS) Retrospective Outcomes Study
RecruitingObservational study
All ages · All sexes · Updated Nov 12, 2026 · NCT03664609Evaluation and Treatment of Neurosurgical Disorders
RecruitingObservational study
Ages 4 to 99 · All sexes · Updated Nov 10, 2026 · NCT00060541A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Nov 10, 2026 · NCT07804615Real-World Study of Foslevodopa/Foscarbidopa to Assess Quality of Life Outcomes in Adult Participants Earlier Within Advanced Parkinson Disease
RecruitingObservational study
Ages 18 to 69 · All sexes · Updated Nov 10, 2026 · NCT07227896Study to Test Effects and Safety of RO7568282 in Early Parkinson's Disease
RecruitingPhase 2
Ages 40 to 85 · All sexes · Updated Nov 9, 2026 · NCT07781644Striatal and Extra-Striatal Cholinergic Terminal Density in LRRK2-PD Mutation
RecruitingObservational study
Ages 45 and older · All sexes · Updated Nov 6, 2026 · NCT07642908Accelerated rTMS for Apathy in Parkinson's Disease
Recruiting
Ages 45 to 85 · All sexes · Updated Nov 5, 2026 · NCT07399496Tributyrin for Progressive Supranuclear Palsy (PSP): Virtual Trial
RecruitingPhase 1/2
Ages 45 and older · All sexes · Updated Nov 5, 2026 · NCT07863180A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
RecruitingPhase 3
Ages 50 to 85 · All sexes · Updated Nov 5, 2026 · NCT07174310Parkinson's Disease in Type 1 Gaucher Disease
RecruitingObservational studyHealthy volunteers welcome
Ages 40 and older · All sexes · Updated Nov 5, 2026 · NCT07886879PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease
RecruitingPhase 1Healthy volunteers welcome
Ages 18 to 99 · All sexes · Updated Nov 2, 2026 · NCT04396873A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease
RecruitingPhase 3
Ages 45 to 75 · All sexes · Updated Nov 2, 2026 · NCT06944522Investigating Basal Ganglia-Cortical Physiology During Sleep and Its Modulation by Adaptive Deep Brain Stimulation in Parkinson Disease
Recruiting
Ages 45 to 75 · All sexes · Updated Oct 30, 2026 · NCT07808346A Study of Buntanetap in Participants With PD
RecruitingPhase 2/3
Ages 40 to 85 · All sexes · Updated Oct 30, 2026 · NCT07284784A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
RecruitingPhase 2
Ages 40 to 80 · All sexes · Updated Oct 30, 2026 · NCT06680830A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations
RecruitingPhase 2
Ages 30 to 80 · All sexes · Updated Oct 28, 2026 · NCT07432958From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.